AstraZeneca to keep 2025 forecast if US pharmaceutical tariffs in line with other sectors

By Yahoo! Finance   |   2 weeks ago
AstraZeneca to keep 2025 forecast if US pharmaceutical tariffs in line with other sectors

AstraZeneca's CEO stated the company will uphold its 2025 sales forecast despite potential U.S. tariffs on EU-made pharma products, as long as they align with other industries' rates. Shares dropped over 4% after first-quarter results fell below analyst predictions.

Read More

Did you find this insightful?